Bellevue Group »

Caris Life Sciences shares owned by Bellevue Group

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Bellevue Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $291k 9.6k 30.25
2025-06-30 $267k 10k 26.72

More positions owned by Bellevue Group

Ionis Pharmaceuticals (IONS)
Argenx Se Sponsored Adr (ARGX)
Revolution Medicines (RVMD)
Neurocrine Biosciences (NBIX)
Alnylam Pharmaceuticals (ALNY)
Vertex Pharmaceuticals Incorporated (VRTX)
Abbott Laboratories (ABT)
Stryker Corporation (SYK)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Agios Pharmaceuticals (AGIO)
Incyte Corporation (INCY)
Scholar Rock Hldg Corp (SRRK)
Akero Therapeutics (AKRO)
Immunocore Hldgs Ads (IMCR)

View all positions for Bellevue Group

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
Silver Lake Group
Neuberger Berman Group
Millennium Management
PointState Capital
OrbiMed Advisors
Ameriprise Financial
ClearBridge Advisors
Canada Pension Plan Investment Board
Alliancebernstein
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences